, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives. Ye F, Bauer JA, Pietenpol JA, Shyr Y (2012) BMC Genomics : S3
    › Primary publication · 23281588 (PubMed) · PMC3535706 (PubMed Central)
  2. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) J Clin Invest 121(7): 2750-67
    › Primary publication · 21633166 (PubMed) · PMC3127435 (PubMed Central)
  3. Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis. Rosenbluth JM, Mays DJ, Jiang A, Shyr Y, Pietenpol JA (2011) Proc Natl Acad Sci U S A 108(5): 2076-81
    › Primary publication · 21245298 (PubMed) · PMC3033306 (PubMed Central)
  4. RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. Bauer JA, Ye F, Marshall CB, Lehmann BD, Pendleton CS, Shyr Y, Arteaga CL, Pietenpol JA (2010) Breast Cancer Res 12(3): R41
    › Primary publication · 20576088 (PubMed) · PMC2917036 (PubMed Central)
  5. Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Adams S, Chakravarthy AB, Donach M, Spicer D, Lymberis S, Singh B, Bauer JA, Hochman T, Goldberg JD, Muggia F, Schneider RJ, Pietenpol JA, Formenti SC (2010) Breast Cancer Res Treat 124(3): 723-32
    › Primary publication · 20878462 (PubMed) · PMC3655407 (PubMed Central)
  6. Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation. Barton CE, Johnson KN, Mays DM, Boehnke K, Shyr Y, Boukamp P, Pietenpol JA (2010) Cell Death Dis : e74
    › Primary publication · 21151771 (PubMed) · PMC3000738 (PubMed Central)
  7. ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Eby KG, Rosenbluth JM, Mays DJ, Marshall CB, Barton CE, Sinha S, Johnson KN, Tang L, Pietenpol JA (2010) Mol Cancer : 95
    › Primary publication · 20429933 (PubMed) · PMC2873442 (PubMed Central)
  8. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA (2010) Clin Cancer Res 16(2): 681-90
    › Primary publication · 20068102 (PubMed) · PMC2892225 (PubMed Central)
  9. mTOR regulates autophagy-associated genes downstream of p73. Rosenbluth JM, Pietenpol JA (2009) Autophagy 5(1): 114-6
    › Primary publication · 19001857 (PubMed) · PMC2792737 (PubMed Central)
  10. Evaluation of p63 and p73 antibodies for cross-reactivity. Rosenbluth JM, Johnson K, Tang L, Triplett T, Pietenpol JA (2009) Cell Cycle 8(22): 3702-6
    › Primary publication · 19855172 (PubMed)